Fingerprint
Dive into the research topics of 'A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically